Aspirin

Generic Name: Aspirin

Brand Names: Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala

Drug Type: Small Molecule

Chemical Formula: C_₉H_₈O_₄

CAS Number: 50-78-2

Unique Ingredient Identifier: R16CO5Y76E

Background: Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...

Indication: Pain, fever, and inflammation
...

Associated Conditions: Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke

Associated Therapies: Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention

Clinical Trials

Mono Antiplatelet and Colchicine Therapy

Phase 4

Completed

Conditions: Acute Coronary Syndrome
Drug-Eluting Stents

Interventions: Drug: Aspirin
Drug: Colchicine

First Posted Date: 2021-07-02

Last Posted Date: 2023-01-04

Lead Sponsor: Wonkwang University Hospital

Target Recruit Count: 200

Registration Number: NCT04949516

Locations: 🇰🇷
Wonkwang University Hospital, Iksan, Korea, Republic of

Outpatient Liquid Aspirin (OLA)

Phase 2

Conditions: Covid19

Interventions: Drug: ASA

First Posted Date: 2021-06-23

Last Posted Date: 2022-01-03

Lead Sponsor: Louisiana State University Health Sciences Center in New Orleans

Target Recruit Count: 200

Registration Number: NCT04937088

Locations: 🇺🇸
Lsuhsc-No, New Orleans, Louisiana, United States

The Clinical Features and Pregnancy Outcomes of CTD Patients

Recruiting

Conditions: Pregnancy Related
Connective Tissue Diseases

Interventions: Drug: Prednisone
Drug: Hydroxychloroquine
Drug: Aspirin
Drug: low molecular weight heparin Enoxaparin

First Posted Date: 2021-06-09

Last Posted Date: 2023-11-18

Lead Sponsor: Qilu Hospital of Shandong University

Target Recruit Count: 126

Registration Number: NCT04918524

Locations: 🇨🇳
Qilu Hospital, Jinan, Shandong, China

ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase

Phase 2

Recruiting

Conditions: Purpura, Thrombocytopenic

Interventions: Drug: Aspirin

First Posted Date: 2021-06-03

Last Posted Date: 2024-08-27

Lead Sponsor: University Hospital, Toulouse

Target Recruit Count: 10

Registration Number: NCT04912505

Locations: 🇫🇷
Toulouse Hospital, Toulouse, France

ASPIRIN: Neurodevelopmental Follow-up Trial

Completed

Conditions: Neurodevelopmental Abnormality

Interventions: Drug: Placebo
Drug: Aspirin

First Posted Date: 2021-05-17

Last Posted Date: 2024-10-21

Lead Sponsor: NICHD Global Network for Women's and Children's Health

Target Recruit Count: 666

Registration Number: NCT04888377

Locations: 🇺🇸
University of Alabama, Birmingham, Birmingham, Alabama, United States
🇺🇸
Columbia University, New York, New York, United States
🇺🇸
University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States

and more 11 locations